NCT06773871View on ClinicalTrials.gov

Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor Conditions

NARecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Myelodysplastic SyndromeCytopenia
Interventions
OTHER

Exercise

Weekly supervised exercise for 12 weeks followed by 12 weeks of non-supervised exercise

OTHER

Control

Remain usual activity level

Trial Locations (2)

2100

NOT_YET_RECRUITING

Rigshospitalet, Copenhagen

Unknown

RECRUITING

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER